DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Hemangiosarcoma; Neoplasms; Ovarian Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Melanoma
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
1Z5YC3ME5N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MITAZALIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms
Unknown
MITAZALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
Q9J81E7VFM
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2981278
1
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
GSK2981278
×
Maximum Phase:
1
First Approval:
None
UNII:
L49V5G013I
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO5S
Molecular Weight:
461.62
AlogP:
4.4
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
10.0
Source:
GSK1614235
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GSK1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEXMARILIMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasms
Unknown
BEXMARILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
SA0O2AK3LA
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04418948
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-04418948
×
Maximum Phase:
1
First Approval:
None
UNII:
I7Z38E70VF
Molecule Type:
Small molecule
Molecular Formula:
C23H20FNO5
Molecular Weight:
409.41
AlogP:
3.59
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
6.0
Source:
GSK159802
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
GSK159802
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NERINDOCIANINE
1
Small molecule
Investigational
Unknown
Unknown
Molecular Imaging; Wounds and Injuries
Unknown
NERINDOCIANINE
×
Maximum Phase:
1
First Approval:
None
UNII:
1GZ5G85KVT
Molecule Type:
Small molecule
Molecular Formula:
C44H52N2O16S5
Molecular Weight:
1025.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD5312
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZD5312
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REGN4018
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
REGN4018
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ETC-159
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ETC-159
×
Maximum Phase:
1
First Approval:
None
UNII:
5L854240DQ
Molecule Type:
Small molecule
Molecular Formula:
C19H17N7O3
Molecular Weight:
391.39
AlogP:
0.53
PSA:
116.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PFK-158
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PFK-158
×
Maximum Phase:
1
First Approval:
None
UNII:
2HOK1JQ203
Molecule Type:
Small molecule
Molecular Formula:
C18H11F3N2O
Molecular Weight:
328.29
AlogP:
4.54
PSA:
42.85
HBD:
0.0
HBA:
#RotB:
3.0
Source:
G1T28-1
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
G1T28-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAFINGOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SAFINGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OWA98U788S
Molecule Type:
Small molecule
Molecular Formula:
C18H39NO2
Molecular Weight:
301.52
AlogP:
4.15
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
16.0
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
QT44II3WZP
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HUMIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Celiac Disease; HTLV-I Infections; Leukemia; Leukemia, Large Granular Lymphocytic
Interleukin-2 receptor beta chain inhibitor
HUMIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ME-344
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Neoplasms
Mitochondrial complex I (NADH dehydrogenase) inhibitor
ME-344
×
Maximum Phase:
1
First Approval:
None
UNII:
843G0TDV51
Molecule Type:
Small molecule
Molecular Formula:
C22H20O4
Molecular Weight:
348.4
AlogP:
4.42
PSA:
69.92
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ETIGILIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms; Ovarian Neoplasms
T-cell immunoreceptor with Ig and ITIM domains inhibitor
ETIGILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
FC1ZF28VIT
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIMOTAXEL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SIMOTAXEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E1M30YOE59
Molecule Type:
Small molecule
Molecular Formula:
C46H57NO15S
Molecular Weight:
896.02
AlogP:
4.67
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
11.0
Source:
CEVIPABULIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CEVIPABULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
P14M0DWS2J
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClF5N6O
Molecular Weight:
464.83
AlogP:
4.07
PSA:
76.37
HBD:
2.0
HBA:
#RotB:
8.0
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-9901
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Unknown
GS-9901
×
Maximum Phase:
1
First Approval:
None
UNII:
U09Q76B8VK
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN9O
Molecular Weight:
477.89
AlogP:
2.96
PSA:
161.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ULILEDLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ULILEDLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
3OX1DBR75G
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FISOGATINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Neoplasms
Unknown
FISOGATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
5Q7R99CKV2
Molecule Type:
Small molecule
Molecular Formula:
C24H24Cl2N4O4
Molecular Weight:
503.39
AlogP:
4.49
PSA:
94.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PAPAIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PAPAIN
×
Maximum Phase:
1
First Approval:
None
UNII:
A236A06Y32
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NG-NITRO-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NG-NITRO-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
LETRAZURIL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LETRAZURIL
×
Maximum Phase:
1
First Approval:
None
UNII:
U8736VCB22
Molecule Type:
Small molecule
Molecular Formula:
C17H9Cl2FN4O2
Molecular Weight:
391.19
AlogP:
3.02
PSA:
91.54
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ANSOFAXINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ANSOFAXINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIVEBRESIB
1
Small molecule
Investigational
Unknown
Unknown
Primary Myelofibrosis
Unknown
MIVEBRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
VR86R11J7J
Molecule Type:
Small molecule
Molecular Formula:
C22H19F2N3O4S
Molecular Weight:
459.47
AlogP:
4.37
PSA:
93.19
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SARS-COV
1
Unknown
Investigational
Unknown
Unknown
Coronavirus Infections; Severe Acute Respiratory Syndrome
Unknown
SARS-COV
×
Maximum Phase:
1
First Approval:
None
UNII:
R7D54R07N5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VACCINIA IMMUNE GLOBULIN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
VACCINIA IMMUNE GLOBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7UB4J759TD
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RP-6530
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RP-6530
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
101
102
103
104
105
106
107
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA